Pyrimidine-based EGFR TK inhibitors in targeted cancer therapy
Adileh Ayati, Setareh Moghimi, Mahsa Toolabi, Alireza Foroumadi
Topics & Concepts
Tyrosine kinaseEGFR inhibitorsTargeted therapyChemistryCancerProtein kinase domainCombination therapyEpidermal growth factor receptorErlotinibCancer researchCancer therapyEpigeneticsPharmacologySignal transductionMedicineBiochemistryInternal medicineGeneMutantLung Cancer Treatments and MutationsHER2/EGFR in Cancer ResearchCancer therapeutics and mechanisms